About Presence

Presence champions the human experience in medicine. We believe that being present is integral to the art and the science of medicine and predicates the quality of medical care. The experience of suffering and the care of those who are suffering is the most poignant of human experiences; we believe both of these can be better addressed in society and in our health-care systems. Adverse effects created by the unintended intrusion of technology include missing obvious disease revealed by the body, dissatisfaction among patients and physicians, and the unplanned loss of social rituals, all of which negatively impact health outcomes.

In a world where we are hyper-linked by technology, we are increasingly separated by a lack of human connection. Even as technology is critical to quality and safety in the delivery of care, it inadvertently creates barriers between the patient and the health-care team.

Presence has unified the best talent to strengthen the human dimension in medicine and medical education, focusing on three areas: harnessing technology for the human experience in medicine; studying and advocating for the patient–physician relationship; and reducing medical errors. By engaging colleagues in every university discipline, from comparative literature to environmental engineering, our goal is to foster research, dialogue, and collaboration among seven Stanford schools to produce measurable and meaningful change.

Presence has benefitted from the living labs of our hospitals and clinics, partnering with our colleagues campus-wide to catalyze scholarship and interdisciplinary applied research via collaborations, a Fellows program, and education programs for medical students, residents, junior faculty, and others. We will also utilize design thinking strategies to propose solutions, apply best practices, and translate knowledge into the educational curriculum. Over time, we anticipate providing a variety of educational events to engage the local community.

Presence supports Stanford Medicine’s Precision Health efforts to define and develop the next generation of care that is proactive, predictive, and precise.

Presence was founded and is directed by Abraham Verghese, MD, whose life work has focused on the experience of suffering and illness and the unique, and sometimes lethal, stresses of being a physician. One constant—whether in his academic work or his novels—has been his love for medicine, his championing of the sanctity of the physician-patient relationship, and, above all, the shared experience we all have of being alive as embodied, mortal beings.

 


Michelle Chiu

Michelle Chiu graduated medical school from Case Western Reserve University School of Medicine and completed internal medicine residency at Stanford University. She is currently a clinical assistant professor in the Division of Hospital Medicine at Stanford Hospital. Outside her clinical work, Dr. Chiu is involved in medical education at the graduate and post-graduate level. She teaches IM Bedside Clinical Reasoning and Physical Diagnosis Rounds, an elective for second-year PA and medical students that focuses on the bridging the gap between classroom physiology and bedside pathology. Additionally, she is involved in APP post-graduate education with current projects in hospital medicine onboarding, CME, and scholarship.


Linda Geng

Linda Geng received a B.S. in Biochemistry/Cell Biology and a B.A. in Psychology, graduating summa cum laude from Rice University in 2006.  She then enrolled in the MSTP program at University of Washington, earning her Ph.D. in 2011 in Molecular/Cellular Biology and her M.D. in 2015.  At Stanford, she has developed an interest in rare, undiagnosed, and inherited diseases, and she has worked with the Stanford Center for Undiagnosed Diseases since her arrival. She was the inaugural resident on a new rotation in Genomic Medicine, and demonstrated the full range of her skills during an outstanding Medicine Grand Rounds two months ago.  

Linda was a winner of the peer-chosen Julian Wolfsohn Award, given to two residents per class each year who demonstrate outstanding performance in clinical judgment, leadership, teaching, and kindness. Linda plans to pursue a one-year NIH fellowship in the Undiagnosed Disease program and a complementing fellowship in Clinical Molecular Genetics.


Errol Ozdalga

Errol Ozdalga is a Clinical Professor of Medicine at Stanford University and the Vice Chair of Communications for the Department of Medicine. He serves as Director of Stanford Medicine 25, a nationally recognized program that emphasizes the importance of bedside clinical skills in modern medicine. As a hospitalist at Stanford Health Care for over 14 years, Dr. Ozdalga is committed to excellence in patient care, medical education, and the advancement of human-centered medicine. His work spans clinical leadership, strategic communications, and innovative efforts to elevate the visibility of Stanford’s medical faculty and programs.


Carla Pugh 

Carla Pugh is Professor of Surgery at Stanford University School of Medicine. She is also the Director of the Technology Enabled Clinical Improvement (T.E.C.I.) Center. Her clinical area of expertise is Acute Care Surgery. Dr. Pugh obtained her undergraduate degree at U.C. Berkeley in Neurobiology and her medical degree at Howard University School of Medicine. Upon completion of her surgical training at Howard University Hospital, she went to Stanford University and obtained a PhD in Education. She is the first surgeon in the United States to obtain a PhD in Education. Her goal is to use technology to change the face of medical and surgical education.

Her research involves the use of simulation and advanced engineering technologies to develop new approaches for assessing and defining competency in clinical procedural skills. Dr. Pugh holds three patents on the use of sensor and data acquisition technology to measure and characterize hands-on clinical skills. Currently, over two hundred medical and nursing schools are using one of her sensor enabled training tools for their students and trainees. Her work has received numerous awards from medical and engineering organizations. In 2011 Dr. Pugh received the Presidential Early Career Award for Scientists and Engineers from President Barak Obama at the White House. She is considered to be a lead, international expert on the use of sensors and motion tracking technology for performance measurement. In 2014 she was invited to give a TEDMED talk on the potential uses of technology to transform how we measure clinical skills in medicine. In April 2018, Dr. Pugh was inducted into the American Institute for Medical and Biological Engineering.


Hannah Valantine

Hannah Valantine recently returned to Stanford as Professor of Medicine. She recently retired this fall from her position as the inaugural NIH Chief Officer for Scientific Workforce Diversity, and a Senior Investigator in the Intramural Research Program at the National Heart, Lung, and Blood Institute (NHLBI). Prior to starting this position in April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at Stanford, a leadership position she held since November 2004. She is nationally recognized for her transformative approaches to diversity and is a recipient of the NIH Director’s Pathfinder Award for Diversity in the Scientific Workforce. Citing NIH Director Dr. Francis Collins’ statement about Dr. Valantine’s accomplisments at NIH, “her laser-like focus on expanding recruitment and retention of the brightest minds regardless of race, ethnicity, gender, disability, and socioeconomic status has produced remarkable results over a few short years.” For example, she established the Distinguished Scholars Program, which has had a dramatic, positive impact on the diversity of tenure-track investigators at NIH. Hannah established the NIH Equity Committee to systematically track and evaluate diversity and inclusion metrics in each NIH Institute and Center’s intramural program. Under her leadership, there has been a significant increase in representation of women as tenure-track and tenured principal investigators (PI), and of African American/Black and Hispanic tenure-track PIs in the Intramural Program. There also has been a significant increase in representation of women in NIH leadership positions, such as Institute/Center Directors and Scientific Directors. she played a major role in taking on workplace harassment at NIH. One of her significant achievements was developing and implementing the first NIH Workplace Climate and Harassment Survey. The findings provided critical data that have informed NIH’s strategies to improve the workplace moving forward. The survey provides a tool (now published) for NIH-funded institutions across the country to assess and improve their workplace climates.

The impact of Dr. Valantine’s work has been felt well beyond the NIH campus. She has made several important inroads into improving diversity and equity among the extramural research community. For example, Hannah designed the Faculty Institutional Recruitment for Sustainable Transformation (FIRST) program that is being implemented by the NIH Common Fund to create cultures of inclusive excellence at NIH-funded institutions. She also guided the National Research Mentoring Network program on coaching and mentoring for grant writing toward successful applications and awards supporting scientists from diverse backgrounds, including those from underrepresented racial and ethnic groups. Since her arrival at NIH, there has been a significant increase in the number of R01 applications and awards that identify African American/Black and Hispanic scientists as the Program Director/Principal Investigator (PD/PI). And for early career scientists, she has focused on career development awards (K-series), the penultimate stage before R01 grants, increasing the number of applications and awards on which African American/Black and Hispanic scientists are identified as PD/PIs, essentially eliminating the racial gap in success rates for K-awards.

At NIH Dr. Valantine established a highly productive research program within the National Heart, Lung, and Blood Institute (NHLBI). She created the Genomic Research Alliance for Transplantation (GRAfT), a consortium of five heart and lung transplant programs in the Washington, D.C. metropolitan area, which has enrolled and is actively following more than 500 patients, 40% of whom are African American/Black. She is using the technology that she co-invented with Steve Quake, professor bioengineering at Stanford — donor-derived cell-free DNA in blood — to monitor organ transplant rejection in the GRAfT cohort, and to understand the mechanisms that explain how and why African Americans/Blacks reject their organ transplants at higher rates than White recipients.

Dr. Valantine was elected to National Academy of Medicine, “for her national leadership in both scientific workforce diversity and cardiac transplantation research. Her data-driven approach in these two important areas has led to game-changing policies and new programs that enriched the nation’s biomedical talent pool and have generated paradigm-shifting innovations in patient care.”


Samantha Wang

Samantha Wang received a B.A. with distinction in Molecular/Cell Biology in 2010.  She then enrolled in medical school at Yale University, earning both an M.D. and a Masters in Health Science in 2015.  While at Yale, Samantha served as a leader for the Yale Women in Medicine Interest Group, and was named a Farr Scholar in Research Excellence.  Given her leadership skills and her superb clinical performance, we were absolutely delighted when she matched at Stanford in 2015.  As a resident, Samantha has thrived as a clinician and as a class leader. She helped create – and now leads – the  Stanford Women in Internal Medicine interest group, and she serves on the Stanford GME Women in Internal Medicine Committee. 

Samantha was also a recipient of the prestigious Julian Wolfsohn Award, and she was one of three members of Stanford’s 2016-2017 Medical Jeopardy team.  Samantha’s current research focus is on the side-effects of new targeted therapies in lung cancer, and she plans a career as a clinician/clinical researcher in Hematology/Oncology. 


Donna Zulman

Donna Zulman, MD, MS, is an Assistant Professor in the Division of Primary Care and Population Health at Stanford University and Associate Director at VA Palo Alto’s Center for Innovation to Implementation (Ci2i). Dr. Zulman received her MD from the University of California, Los Angeles. After completing her residency in Internal Medicine at the University of Michigan, she received a Masters in Health and Health Care Research through the Robert Wood Johnson Clinical Scholars Program at the University of Michigan and the Ann Arbor VA.

Dr. Zulman received a VA Health Services Research & Development Career Development Award (2013-2018) to study health care delivery interventions for Veterans with complex medical needs. Currently, Dr. Zulman's research focuses on improving health care delivery for patients with multiple chronic conditions and complex medical and social needs and optimizing health-related technology to personalize care and improve outcomes for high-risk patients. She is one of the PIs of the national VA Virtual Care Consortium of Research, and directs the VA Quality Enhancement Research Initiative focused on implementing and evaluating virtual care for Veterans with access barriers. Dr. Zulman is also an Associate Editor for the Journal of General Internal Medicine.

In addition to research, Dr. Zulman is actively involved in teaching and mentoring students, residents, and fellows at Stanford and the VA. She directs a course at Stanford, entitled, Methods for Health Care Delivery Innovation, Implementation, and Evaluation. She was the recipient of the Stanford McCormick Award for the Advancement of Women in Academic Medicine in 2016 and an Exceptional Mentor Award from the American Medical Women’s Association in 2020.